Healius (HLS) AGM 2024 summary

Opening remarks and agenda

• Board members and executive team introduced; agenda included re-elections, remuneration report, and constitutional changes.

• Polls for all items of business were declared open at the start.

Financial performance review

• Pathology volumes increased 4.5% and revenues grew 5.9% year-to-date; EBIT for 1H25 expected to be in line with 1H24.

• Lumus Imaging exam volumes up 16% and revenue up 11% year-to-date; EBIT expected to rise 40% in 1H25.

• Agilex revenue grew 20.8%, EBITDA up 102.3%, and EBIT nearly tripled to AUD 5.1 million.

• Net debt and interest cover improved, with plans to further reduce debt post-Lumus sale.

Board and executive committee updates

• Paul Anderson appointed CEO in March 2024; Steve Humphries became CFO.

• Five new members joined the leadership team, focused on improved results.

• Two new directors joined in FY24; ongoing board renewal planned.

• Ravi Jeyaraj resigned due to an overseas role; board close to finalizing a new Audit Committee chair.